Innovations

Nigeria’s Reference Laboratory to provide capacity for Africa

The National Reference Laboratory (NRL), has been selected as one of 12 laboratories in Africa that will provide genomic sequencing capacity for the Coronavirus (COVID-19) pandemic in the continent.

Dr Chikwe Ihekweazu, Director General, Nigeria Centre for Disease Control (NCDC), disclosed this in an interview with News Agency of Nigeria(NAN), on Saturday in Abuja.

NAN reports that the COVID-19 genome sequencing laboratory network was launched with several African countries alongside Nigeria by the World Health Organisation (WHO) and Africa Centre for Disease Control.

Read:  Nigerian agri-tech startups named winner of $1.5m AYuTe Africa Challenge

A statement jointly issued by both organisations had explained that the network of laboratories had been established to reinforce genome sequencing of the virus on the continent.

According to the Director, Africa CDC and WHO Regional Director, this partnership is important in determining the response to various SARS-CoV-2 strains and in helping countries manage localised or imported transmission.

“Genomic sequencing provides better understanding of the pandemic through more precise identification of transmission clusters.

Speaking with NAN, Ihekweazu said over the last four years, they have focused on establishing the research functions of the NCDC National Reference Laboratory.

Read:  African startups Moove, Lori partner to propel financing for African logistics.

According to the NCDC DG, these functions include our genetic sequencing capacity, biobanking and similar functions

“We are proud that we can now use this capacity to not only serve Nigerians, but to support neighbouring countries in West Africa,” he said.

He furthermore appreciated the Africa CDC and WHO for the support provided thus far.

Ihekweazu said that the agency is committed to working together for the benefit of the region.

Read:  Nigerian entrepreneur Temie Giwa-Tubosun wins Jack Ma's African business hero award

NAN reports that these laboratories selected will henceforth provide capacity for sequencing of the virus and not just molecular detection.

Sequencing of the virus will provide additional insights needed for the development of vaccines, therapeutics and other tools required by the African region to fight this pandemic.

Genomic sequencing is also used to understand the occurence of virus mutation and develop the required response to this. (NAN)

pmnewsnigeria

Related posts

SystemSpecs Announces Summer Coding Camp for Students

NigGal

Nigerian startup, EZFarming secures $150,000 investment from 500 Startups

NigGal

Nigerian-Owned Coins App ease Cross-Border Payments Through its Unique Blockchain System

NigGal

Nigerian startup Moove Raises $23m in Series A Funding.

NigGal

Nigerian e-health startup First Medtrade launches online medical market

NigGal

Nigerian social payments app Bundle launches operations in Ghana.

NigGal

Leave a Comment